2023, BioTech, Health Technology and Telehealth

Emerging trends in the European HealthTech M&A market 2023

Lloyd Price

SEPTEMBER 2, 2023

Exec Summary: The European HealthTech M&A market is expected to remain active in 2023, albeit with some slowdown from the record-breaking levels seen in 2022. This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies.

Life Science

Life Science Digital Health EHR BioTech

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

NOVEMBER 20, 2023

Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. Accessed November 2023. Accessed November 2023.

Life Science

Life Science Digital Health Drug Development Patient Experience

Bonus Features, HLTH Edition – October 11, 2023 – Announcements from Best Buy, General Catalyst, Google Cloud, Microsoft, Walgreens, and more

Healthcare IT Today

OCTOBER 11, 2023

Welcome to the special HLTH 2023 edition of Healthcare IT Today Bonus Features. Samsung Health is using the b.well Connected Health Platform to help users to create a longitudinal health record and connect to providers at Walgreens and various hospital networks.

Life Science

Life Science EHR BioTech RCM

Connected Health Pulse

Emerging trends in the European HealthTech M&A market 2023

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Bonus Features, HLTH Edition – October 11, 2023 – Announcements from Best Buy, General Catalyst, Google Cloud, Microsoft, Walgreens, and more

Stay Connected